PCSK9 Inhibitors, A Historic Change in Cardiovascular Care

by Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA Every generation or so, each medical discipline hopes to experience a revolution of monumental proportions. Statins, released in the 1980s, were the last cholesterol modifying medications that dramatically altered our ability to decrease heart attacks and strokes. Now we have the PCSK9 inhibitors. With them we…

Read More